SMC - January 2020 decisions

13 January 2020 - Medicines which can be used to treat prostate cancer, primary progressive multiple sclerosis, a rare form ...

Read more →

NICE and the SMC have published recommendations on Shionogi’s Mulpleo (lusutrombopag), approving its use for the treatment of severe thrombocytopenia in adult patients with chronic liver disease undergoing invasive procedures

12 December 2019 - Mulpleo (lusutrombopag) is the first licensed treatment to be made available through the National Health Service ...

Read more →

Ovarian cancer drug olaparib approved in Scotland as new treatment

9 December 2019 - A maintenance treatment for patients with advanced ovarian cancer has been approved for use in Scotland. ...

Read more →

SMC - December 2019 decisions

9 December 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Breast and kidney cancer drugs get approval for use across Scotland's NHS

11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used ...

Read more →

SMC - November 2019 decisions

11 November 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

AbbVie’s Skyrizi (risankizumab) accepted for use within NHS Scotland

7 October 2019 - SMC recommendation based on results from four pivotal Phase 3 studies, UltIMMa-1, UltIMMa-2, IMMvent and IMMhance evaluating ...

Read more →

SMC - October 2019 decisions

7 October 2019 - Medicines which can be used to treat lymphoma, lung cancer, breast cancer and psoriasis have today been ...

Read more →

Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)

12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...

Read more →

SMC U-turn for Vertex’s CF drugs

12 September 2019 - Vertex has announced that following a change of heart by the SMC, eligible cystic fibrosis patients ...

Read more →

SMC - September 2019 decisions

9 September 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Scottish Medicines Consortium accepts Buvidal for treatment of opioid dependence

13 August 2019 - The Scottish Medicines Consortium has accepted weekly and monthly Buvidal for treatment of opioid dependence in ...

Read more →

‘Not acceptable’ disappointment as cystic fibrosis drug not approved in Scotland

12 August 2019 - People with cystic fibrosis in Scotland will continue to be denied potentially life-extending drugs after they ...

Read more →

Cystic fibrosis drugs rejected for use by NHS in Scotland

12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland. ...

Read more →

SMC - August 2019 decisions

12 August 2019 - The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →